4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001567619-21-014631
Director bought 150,000 shares at an average $2.72 ($408,515)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-04 | Purchase : show line 1 in the form | +100,000 | $2.69 | $268,590 | 39,200,000 | I |
| 2021-08-05 | Purchase : show line 2 in the form | +25,000 | $2.77 | $69,295 | 39,225,000 | I |
| 2021-08-06 | Purchase : show line 3 in the form | +25,000 | $2.83 | $70,630 | 39,250,000 | I |
| Open-market purchases · 150,000 sh · avg $2.72 · $408,515 | ||||||
Loading xslF345X03/doc1.xml…